Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (201-210 of 490) with videos related to

Pageof 49
Sort By:
Blood|January 8, 2000
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemiaR A Clift, J Radich, F R Appelbaum, et al.
Bone Marrow Transplantation|June 1, 1996
Factors influencing collection of peripheral blood stem cells in patients with multiple myelomaT Demirer, C D Buckner, T Gooley, et al.
Blood|August 1, 1994
In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cellsR G Andrews, R A Briddell, G H Knitter, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancerT Demirer, C D Buckner, F R Appelbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 1998
Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autograftsR Storb, R Raff, H J Deeg, et al.
The New England Journal of Medicine|June 21, 1990
Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemiaD W Niederwieser, F R Appelbaum, G Gastl, et al.
Cancer Treatment and Research|January 1, 1993
High-dose radioimmunotherapy of lymphomasO W Press, J Eary, C C Badger, et al.
Blood|October 1, 1996
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcomeW I Bensinger, C D Buckner, C Anasetti, et al.
Bone Marrow Transplantation|March 1, 1990
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicityS I Bearman, F B Petersen, R A Schor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Regimen-related toxicity in patients undergoing bone marrow transplantationS I Bearman, F R Appelbaum, C D Buckner, et al.
Pageof 49

Showing results (201-210 of 490) with videos related to

Sort By:
Pageof 49
Blood|January 8, 2000
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemiaR A Clift, J Radich, F R Appelbaum, et al.
Bone Marrow Transplantation|June 1, 1996
Factors influencing collection of peripheral blood stem cells in patients with multiple myelomaT Demirer, C D Buckner, T Gooley, et al.
Blood|August 1, 1994
In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cellsR G Andrews, R A Briddell, G H Knitter, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancerT Demirer, C D Buckner, F R Appelbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 1998
Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autograftsR Storb, R Raff, H J Deeg, et al.
The New England Journal of Medicine|June 21, 1990
Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemiaD W Niederwieser, F R Appelbaum, G Gastl, et al.
Cancer Treatment and Research|January 1, 1993
High-dose radioimmunotherapy of lymphomasO W Press, J Eary, C C Badger, et al.
Blood|October 1, 1996
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcomeW I Bensinger, C D Buckner, C Anasetti, et al.
Bone Marrow Transplantation|March 1, 1990
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicityS I Bearman, F B Petersen, R A Schor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Regimen-related toxicity in patients undergoing bone marrow transplantationS I Bearman, F R Appelbaum, C D Buckner, et al.
Pageof 49